Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.690
-0.010 (-0.37%)
Apr 25, 2025, 12:29 PM EDT - Market open
Anixa Biosciences Employees
As of October 31, 2024, Anixa Biosciences had 5 total employees, including 4 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,496,600
Market Cap
86.60M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ANIX News
- 11 days ago - Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio - PRNewsWire
- 16 days ago - Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology - PRNewsWire
- 24 days ago - Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th - PRNewsWire
- 4 weeks ago - Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines - PRNewsWire
- 4 weeks ago - Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine - PRNewsWire
- 5 weeks ago - Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th - PRNewsWire
- 6 weeks ago - Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties - PRNewsWire
- 7 weeks ago - Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th - PRNewsWire